1832 Asset Management L.P. Altamira Therapeutics Ltd. Transaction History
1832 Asset Management L.P.
- $55.8 Billion
- Q3 2024
About Altamira Therapeutics Ltd.
- Ticker CYTO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,009,710
- Market Cap $101K
- Description
- Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is also involved in the development of RNA therapeutics for extrahepatic therapeutic targets, includin...